{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T14:13:34Z","timestamp":1771078414759,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"9351","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1016\/s0140-6736(03)12118-6","type":"journal-article","created":{"date-parts":[[2003,1,17]],"date-time":"2003-01-17T14:53:32Z","timestamp":1042815212000},"page":"27-32","source":"Crossref","is-referenced-by-count":101,"title":["Accuracy of pharmaceutical advertisements in medical journals"],"prefix":"10.1016","volume":"361","author":[{"given":"Pilar","family":"Villanueva","sequence":"first","affiliation":[]},{"given":"Salvador","family":"Peir\u00f3","sequence":"additional","affiliation":[]},{"given":"Juli\u00e1n","family":"Librero","sequence":"additional","affiliation":[]},{"given":"Inmaculada","family":"Pereir\u00f3","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(03)12118-6_bib1","first-page":"958","article-title":"Can the advertisements in a reputable medical journal promote quackery?","volume":"22","author":"Anonymous","year":"1894","journal-title":"JAMA"},{"key":"10.1016\/S0140-6736(03)12118-6_bib2","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1001\/jama.1991.03460180100043","article-title":"Editors and advertisements: what responsibility do editors have for the advertisements in their journals?","volume":"265","author":"Rennie","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/S0140-6736(03)12118-6_bib3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/BF02599916","article-title":"Policies, practices, and attitudes of North American medical journal editors","volume":"10","author":"Wilkes","year":"1995","journal-title":"J Gen Intern Med"},{"key":"10.1016\/S0140-6736(03)12118-6_bib4","doi-asserted-by":"crossref","first-page":"912","DOI":"10.7326\/0003-4819-116-11-912","article-title":"Pharmaceutical advertising in leading medical journals: experts' assessments","volume":"116","author":"Wilkes","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0140-6736(03)12118-6_bib5","first-page":"1622","article-title":"Kemp T Evidence based advertising? Only two fifths of advertisements cited published, peer reviewed references","volume":"315","author":"Mindell","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/S0140-6736(03)12118-6_bib6","first-page":"47","article-title":"Methodologic quality and relevance of references in pharmaceutical advertisements in a Canadian medical journal","volume":"151","author":"Lexchin","year":"1994","journal-title":"Can Med Assoc J"},{"key":"10.1016\/S0140-6736(03)12118-6_bib7","first-page":"1622","article-title":"Evidence based advertising? Half of drug advertisements in BMJ over six months cited no supporting evidence","volume":"315","author":"Smart","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/S0140-6736(03)12118-6_bib8","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1136\/bmj.315.7122.1623","article-title":"More convincing evidence of efficacy needs to be cited","volume":"315","author":"Greenhalgh","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/S0140-6736(03)12118-6_bib9","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/bmj.308.6926.474a","article-title":"Data in drug advertisements","volume":"308","author":"Healing","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/S0140-6736(03)12118-6_bib10","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1056\/NEJM199210153271606","article-title":"The publication of sponsored symposiums in medical journals","volume":"327","author":"Bero","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(03)12118-6_bib11","series-title":"Evidence-Based Medicine: how to practice and teach EBM","author":"Sackett","year":"1997"},{"key":"10.1016\/S0140-6736(03)12118-6_bib12","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1161\/01.CIR.99.15.2055","article-title":"Trends in antihypertensive drug advertising, 1985\u20131996","volume":"99","author":"Wang","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/S0140-6736(03)12118-6_bib13","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM199411173312007","article-title":"Therapeutic-class wars: drug promotion in a competitive marketplace","volume":"331","author":"Kessler","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(03)12118-6_bib14","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJM200005183422009","article-title":"Is academic medicine for sale?","volume":"342","author":"Angell","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(03)12118-6_bib15","unstructured":"Real Decreto 1416\/1994, de 25 de junio, por el que se regula la publicidad de los medicamentos de uso humano [Royal Decree 1416\/1994, June 25, which regulates advertisement of drugs for human use]. Boletin Oficial del Estado; 1994 July 29."},{"key":"10.1016\/S0140-6736(03)12118-6_bib16","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1001\/jama.1990.03450180073032","article-title":"The federal regulation of prescription drug advertising and promotion","volume":"264","author":"Kessler","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/S0140-6736(03)12118-6_bib17","first-page":"1208","article-title":"Drug product advertising and prescribing: a review of the evidence","volume":"34","author":"Smith","year":"1977","journal-title":"Am J Hosp Pharm"},{"key":"10.1016\/S0140-6736(03)12118-6_bib18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0002-9343(82)90911-1","article-title":"Scientific versus commercial sources of influence on the prescribing behavior of physicians","volume":"73","author":"Avorn","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/S0140-6736(03)12118-6_bib19","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/002204269202200212","article-title":"The influence of pharmaceutical industry advertising on physician prescribing","volume":"22","author":"Caudill","year":"1992","journal-title":"J Drug Issues"},{"key":"10.1016\/S0140-6736(03)12118-6_bib20","first-page":"1257","article-title":"The influence of drug advertisements","volume":"2","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(03)12118-6_bib21","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1056\/NEJM199008303230921","article-title":"Voluntary control of drug promotion in Sweden","volume":"323","author":"Perman","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(03)12118-6_bib22","first-page":"1997","article-title":"Code of marketing practices: voluntary self-regulation for the Pharmaceutical Manufacturers Association of Canada","volume":"43","author":"Lexchin","year":"1997","journal-title":"Can Fam Physician"},{"key":"10.1016\/S0140-6736(03)12118-6_bib23","doi-asserted-by":"crossref","first-page":"590","DOI":"10.5694\/j.1326-5377.1997.tb138906.x","article-title":"MaLAM, a medical lobby for appropriate marketing of pharmaceuticals","volume":"167","author":"Mansfield","year":"1997","journal-title":"Med J Aust"},{"key":"10.1016\/S0140-6736(03)12118-6_bib24","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/bmj.300.6720.307","article-title":"Promotion by the British pharmaceutical industry, 1983\u201388: a critical analysis of self regulation","volume":"300","author":"Herxheimer","year":"1990","journal-title":"BMJ"},{"key":"10.1016\/S0140-6736(03)12118-6_bib25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2190\/EKEP-D9JE-31A4-KTE5","article-title":"Canadian marketing codes: how well are they controlling pharmaceutical promotion","volume":"24","author":"Lexchin","year":"1994","journal-title":"Int J Health Serv"},{"key":"10.1016\/S0140-6736(03)12118-6_bib26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2190\/B81X-4A53-TY5M-C2HR","article-title":"Self-regulatory codes of conduct: are they effective in controlling pharmaceutical representatives' presentations to general medical practitioners?","volume":"28","author":"Roughead","year":"1998","journal-title":"Int J Health Serv"},{"key":"10.1016\/S0140-6736(03)12118-6_bib27","doi-asserted-by":"crossref","first-page":"671","DOI":"10.5694\/j.1326-5377.1994.tb126915.x","article-title":"Pharmaceutical advertisements in Australian medical publications\u2014have they improved?","volume":"161","author":"Carandang","year":"1994","journal-title":"Med J Aust"},{"key":"10.1016\/S0140-6736(03)12118-6_bib28","author":"Medical Lobby for Appropriate Marketing. Available at"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673603121186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673603121186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T01:24:04Z","timestamp":1583976244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673603121186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":28,"journal-issue":{"issue":"9351","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["S0140673603121186"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(03)12118-6","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}